EUVIMEDEUVIMED entdecken
Crossref

Rh(III)-catalyzed ortho-C–H Functionalization of N-arylphthalazinones with Cyclic Enones

Basi V. Subba Reddy, B. Jagan Mohan Reddy, Laudia Srinivas, T. Ravi Teja, Chidrawar Ajay, Yogananda Chary Devulapalli

Synlett · 01.09.2026 · 37 (14) · 1437-1441

DOI: 10.1055/a-2854-6359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, erschienen am 01.09.2026. Verfasst von Basi V. Subba Reddy und 5 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Gefördert von: UGC, New Delhi, India.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rh(III)-catalyzed direct ortho-C–H bond functionalization of N-arylpthalazinones with cyclic enones has been developed for the synthesis of arylated cyclic ketones. A novel class of 2-(2-(3-oxocycloalkyl)aryl)-2,3-dihydrophthalazine-1,4-dione derivatives were synthesized in good to excellent yields with a wide substrate scope and good functional group tolerance. This reaction represents the first ortho-C–H functionalization of N-arylpthalazinones with cyclic enones by transition metal catalysis.

Förderung

  • UGC, New Delhi, India

Zitieren

APA

Reddy, B. V. S., Reddy, B. J. M., Srinivas, L., Teja, T. R., Ajay, C., & Devulapalli, Y. C. (2026). Rh(III)-catalyzed ortho-C–H Functionalization of N-arylphthalazinones with Cyclic Enones. Synlett, 37(14), 1437-1441. https://doi.org/10.1055/a-2854-6359

Vancouver

Reddy BVS, Reddy BJM, Srinivas L, Teja TR, Ajay C, Devulapalli YC. Rh(III)-catalyzed ortho-C–H Functionalization of N-arylphthalazinones with Cyclic Enones. Synlett. 2026;37(14):1437-1441. doi:10.1055/a-2854-6359

BibTeX
@article{Reddy2026,
  author = {Reddy, Basi V. Subba and Reddy, B. Jagan Mohan and Srinivas, Laudia and Teja, T. Ravi and Ajay, Chidrawar and Devulapalli, Yogananda Chary},
  title = {Rh(III)-catalyzed ortho-C–H Functionalization of N-arylphthalazinones with Cyclic Enones},
  journal = {Synlett},
  year = {2026},
  volume = {37},
  number = {14},
  pages = {1437--1441},
  doi = {10.1055/a-2854-6359}
}
Kostenlos starten →